|
RTOG 0525: Phase III Trial Comparing Conventional Adjuvant
Temozolomide with Dose-Intensive Temozolomide in Patients with
Newly Diagnosed Glioblastoma
For more information on the above clinical
trials:
Cheryl Patz, RN, OCN, CCRC, 360.715.4133
Return to previous page
|